ATE354363T1 - Kombination von drei substanzen zur vorbeugung und behandlung von arthritis - Google Patents
Kombination von drei substanzen zur vorbeugung und behandlung von arthritisInfo
- Publication number
- ATE354363T1 ATE354363T1 AT01273196T AT01273196T ATE354363T1 AT E354363 T1 ATE354363 T1 AT E354363T1 AT 01273196 T AT01273196 T AT 01273196T AT 01273196 T AT01273196 T AT 01273196T AT E354363 T1 ATE354363 T1 AT E354363T1
- Authority
- AT
- Austria
- Prior art keywords
- salt
- substances
- prevent
- combination
- arthritis
- Prior art date
Links
- 206010003246 arthritis Diseases 0.000 title abstract 3
- 239000000126 substance Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 7
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical class O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 abstract 3
- 229920002683 Glycosaminoglycan Polymers 0.000 abstract 2
- 150000002337 glycosamines Chemical class 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003674 animal food additive Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000013373 food additive Nutrition 0.000 abstract 1
- 239000002778 food additive Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Animal Husbandry (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Physiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001000394 | 2001-01-05 | ||
| JP2001146465 | 2001-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE354363T1 true ATE354363T1 (de) | 2007-03-15 |
Family
ID=26607347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01273196T ATE354363T1 (de) | 2001-01-05 | 2001-12-27 | Kombination von drei substanzen zur vorbeugung und behandlung von arthritis |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7138386B2 (de) |
| EP (1) | EP1356811B1 (de) |
| JP (1) | JPWO2002055074A1 (de) |
| AT (1) | ATE354363T1 (de) |
| CA (1) | CA2433714C (de) |
| DE (1) | DE60126829T2 (de) |
| WO (1) | WO2002055074A1 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2433713A1 (en) * | 2001-01-05 | 2002-07-18 | Kyowa Hakko Kogyo Co., Ltd. | Preventives for arthritis |
| EP1547594A4 (de) * | 2002-09-30 | 2007-08-29 | Kyowa Hakko Kogyo Kk | MITTEL ZUR PRûVENTION ODER BEHANDLUNG VON DEKUBITUS |
| EP1559425A4 (de) * | 2002-11-01 | 2007-12-19 | Kyowa Hakko Kogyo Kk | Perorale zubereitung zur prävention oder behandlung von atopischer dermatitis |
| CN1232256C (zh) * | 2003-03-27 | 2005-12-21 | 中国人民解放军第三军医大学 | N-乙酰氨基葡萄糖在制备治疗自身免疫反应所致的局部损伤或全身症状的药物中的应用 |
| DK200301128A (da) | 2003-08-05 | 2005-02-06 | Thomsen Joern Oddershede | Tilskudspræparat |
| ITMI20032614A1 (it) * | 2003-12-30 | 2005-06-30 | Altergon Sa | Nuova composizione comprendente cs |
| US20070293559A1 (en) * | 2004-09-21 | 2007-12-20 | Erika Kagami | Orally Administered Agent For Preventing Or Improving Dry Station Of Skin |
| US20080102042A1 (en) * | 2004-10-28 | 2008-05-01 | Kyowa Hakko Kogyo Co., Ltd. | Oral Composition |
| FR2879075B1 (fr) * | 2004-12-15 | 2007-01-19 | Adisseo France Sas Soc Par Act | Procede de preparation de granules de principe actif hydrophile par extrusion |
| FR2879074B1 (fr) * | 2004-12-15 | 2007-08-03 | Adisseo France Sas Soc Par Act | Granules de principe actif hydrophile |
| US20060228431A1 (en) * | 2005-04-07 | 2006-10-12 | Eben David J | Nutriceutical tea |
| NZ565108A (en) * | 2005-07-07 | 2011-10-28 | Farnam Co Inc | Sustained release pharmaceutical compositions for highly water soluble drugs |
| WO2007044945A2 (en) * | 2005-10-13 | 2007-04-19 | Gu, Jennifer, L. | Mineral collagen chelates and methods of making and using same |
| JP2008120716A (ja) * | 2006-11-10 | 2008-05-29 | Eisai Food Chemical Kk | 抗炎症剤 |
| EP2932958A1 (de) | 2007-02-22 | 2015-10-21 | Beiersdorf AG | Kosmetische und pharmazeutische Anwendungen von N-acetylhydroxyprolin |
| JP5270893B2 (ja) * | 2007-10-01 | 2013-08-21 | サントリーホールディングス株式会社 | 異味成分を含有する速崩壊性顆粒の製造方法 |
| US20090209487A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | Compositions of carbohydrates as dietary supplements |
| US20090209486A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | Compositions of carbohydrates as dietary supplements |
| US20090311238A1 (en) * | 2008-06-11 | 2009-12-17 | Crandall Wilson T | Topical composition and treatment method for cartilage damage |
| WO2010030470A1 (en) * | 2008-09-11 | 2010-03-18 | Gilad Gad M | Agmatine containing dietary supplements, nutraceuticals, and foods |
| US8916612B2 (en) | 2008-09-11 | 2014-12-23 | Gad Gilad | Agmatine containing dietary supplements, nutraceuticals, and foods |
| BE1019135A5 (nl) * | 2010-01-08 | 2012-03-06 | Lab Smeets Nv | Voedingssupplement bevattende glucosamine. |
| DE102011107854A1 (de) * | 2011-07-01 | 2013-01-03 | Stefanie Alber | Futtermittel |
| JP6076624B2 (ja) * | 2012-06-07 | 2017-02-08 | 日本メナード化粧品株式会社 | 幹細胞から中胚葉系細胞、内胚葉系細胞又は中内胚葉細胞への分化誘導剤 |
| KR101775662B1 (ko) | 2017-01-25 | 2017-09-19 | 주식회사 구펍 | 기능성 사료 조성물 및 그 제조 방법 |
| JP7780177B2 (ja) * | 2021-10-06 | 2025-12-04 | 国立大学法人 和歌山大学 | プロテオグリカン及びコンドロイチン硫酸の製造方法 |
| CN121059761A (zh) * | 2025-09-29 | 2025-12-05 | 辽宁未来生物科技有限公司 | 一种玉米胚芽骨胶原粉及其在改善骨关节炎中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR4727M (fr) | 1965-11-04 | 1967-02-06 | Tecpan Sa | La l.hydroxyproline et ses associations médicamenteuses dans le traitement des maladies rhumatismales. |
| US5364845C1 (en) | 1993-03-31 | 2002-09-10 | Nutramax Lab Inc | Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue |
| FR2770777B1 (fr) | 1997-11-10 | 2000-02-25 | Fabre Pierre Dermo Cosmetique | Composition synergique associant de l'acs et/ou de l'adn a de l'hydroxyproline ainsi que leurs applications en nutritherapie et en cosmetologie |
| EP1083929B1 (de) * | 1998-06-05 | 2007-02-14 | Nutramax Laboratories, Inc. | Verwendung von anabolika, anti-katabolischen mitteln, antioxidanzien und analgetika zum schutz, zur behandlung und reparation von bindegeweben in menschen und tieren |
| US6159485A (en) * | 1999-01-08 | 2000-12-12 | Yugenic Limited Partnership | N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use |
-
2001
- 2001-12-27 JP JP2002555808A patent/JPWO2002055074A1/ja active Pending
- 2001-12-27 US US10/250,373 patent/US7138386B2/en not_active Expired - Fee Related
- 2001-12-27 DE DE60126829T patent/DE60126829T2/de not_active Expired - Fee Related
- 2001-12-27 WO PCT/JP2001/011541 patent/WO2002055074A1/ja not_active Ceased
- 2001-12-27 EP EP01273196A patent/EP1356811B1/de not_active Expired - Lifetime
- 2001-12-27 AT AT01273196T patent/ATE354363T1/de not_active IP Right Cessation
- 2001-12-27 CA CA002433714A patent/CA2433714C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1356811B1 (de) | 2007-02-21 |
| DE60126829T2 (de) | 2007-12-06 |
| CA2433714A1 (en) | 2002-07-18 |
| EP1356811A4 (de) | 2005-08-17 |
| US7138386B2 (en) | 2006-11-21 |
| WO2002055074A1 (en) | 2002-07-18 |
| US20040053884A1 (en) | 2004-03-18 |
| CA2433714C (en) | 2009-03-03 |
| JPWO2002055074A1 (ja) | 2004-05-13 |
| DE60126829D1 (de) | 2007-04-05 |
| EP1356811A1 (de) | 2003-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE354363T1 (de) | Kombination von drei substanzen zur vorbeugung und behandlung von arthritis | |
| TR200500221T2 (tr) | Farmasötik Maddeler Olarak Bisiklik Amino Asitler | |
| ATE388951T1 (de) | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes | |
| ATE313532T1 (de) | Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen | |
| EA200001258A1 (ru) | Пирролзамещенные 2-индолиноны (варианты), фармацевтическая композиция (варианты), способ модулирования каталитической активности протеинкиназы, способ лечения или профилактики нарушения в организме, связанного с протеинкиназой | |
| DE60112766D1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
| DE602004021847D1 (de) | Verfahren zur prävention und behandlung von diabetes mit neurturin | |
| DE60313434D1 (de) | Verfahren und zusammensetzungen zur behandlung von hyperproliferativen zuständen | |
| DE60135904D1 (de) | Arzneien zur behandlung von nervenerkrankungen | |
| BR0313436A (pt) | Produtos alimentìcios contendo proteìna animal e possuindo retenção melhorada de umidade | |
| ES2184300T3 (es) | Derivados de aminoacidos utiles para tratar el accidente vascular encefalico. | |
| ATE289204T1 (de) | Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie | |
| EP1354584A4 (de) | Präventiva für arthritis | |
| MXPA06007007A (es) | Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores. | |
| NO20062229L (no) | Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er) | |
| DE69827163D1 (de) | Phytase zur vorbeugung oder behandlung von mastitis | |
| IL153182A0 (en) | Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv | |
| ATE397924T1 (de) | Satraplatin zur behandlung von resistenten oder refrkatären tumoren | |
| DE60334289D1 (de) | Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen | |
| DE60222298D1 (de) | Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem beta-lactam-antibiotikum | |
| DE602004025001D1 (de) | Verbindungen zur behandlung von neuropathischen schmerzen und migräne | |
| ATE350034T1 (de) | Verwendung von epothilone zur behandlung hyperparathyreoidismus | |
| BR0215014A (pt) | Método aperfeiçoado para o tratamento de produtos alimentìcios, produtos de alimentos para animais ou produtos agrìcolas com um composto de polieno antifúngico | |
| DE60229502D1 (de) | Verfahren und mittel zur behandlung von krebs bei hunden | |
| DE60215947D1 (de) | Pyridin-2-yl-methylamin-derivate zur behandlung von opiatsucht |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |